Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pharmacy Giant Walgreens Taps Tim Wentworth to Be CEO
The incoming chief executive faces a tough challenge, with a core business under pressure due to pharmacy-benefit managers such as his former employer Express Scripts.
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower
Ozempic, Oprah and apologies: WeightWatchers says there’s no shame in being overweight, or in taking new weight-loss drugs. Source link
The World Needs New Antibiotics, but the Business Model Is Broken
New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts
Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion
The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses. Source link